Results

Total Results: 744 records

Showing results for "presence".

21. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-stenting_research-protocol.pdf
    August 19, 2011 - KQs: • Key Question 1: For patients undergoing diagnostic coronary angiography to evaluate the presence … a) During diagnostic coronary angiography for the evaluation of the presence/extent of CAD and the potential … a) During diagnostic coronary angiography for the evaluation of the presence/extent of CAD and the … KQs 1, 4a, and 5a: Patients who undergo diagnostic coronary angiography and are evaluated for the presence … 2012 Key Question 1 For patients undergoing diagnostic coronary angiography to evaluate the presence

22. Postpartum Care for Women Up to One Year After Pregnancy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
    April 25, 2022 - Immigration status o Barriers to transportation to healthcare facility o Paid family leave policies (e.g., presence … Medicaid], insurance coverage of postpartum care, Medicaid insurance coverage extension or expansion) o Presence … o Presence versus absence of a supportive partner o Infant health (e.g., neonatal intensive care unit … Medicaid], insurance coverage of postpartum care, Medicaid insurance coverage extension or expansion) o Presence … o Presence versus absence of a supportive partner o Infant health (e.g., neonatal intensive care unit

23. CER 174 Executive Summary: Imaging for the Pretreatment of Small Cell Lung Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/lung-cancer-staging_executive.pdf
    April 01, 2016 - FDG PET/CT; 1 study, n=28 Standard staging* only; 1 study, n=25 Presence of metastases to osseous … None MDCT only; 1 study, n=118 EBUS only; 1 study, n=36 Presence of metastases to adrenal glands … None MDCT only; 1 study, n=120 Presence of metastases to the liver None MDCT only; 1 study, n=120 … Presence of metastases to the spleen None MDCT only; 1 study, n=120 Presence of any distant metastases … Our findings suggest that clinicians evaluating patients for the presence of osseous metastases may

24. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/undescended-testicle_research-protocol.pdf
    September 02, 2011 - However, the value and predictive power of these approaches for identifying the presence and location … For determining a course of treatment, is imaging equivalent to laparoscopy in determining the presence … Ability to correctly identify the presence and/or location of the testis 2. … Urology 8 : Laparoscopy: minimally invasive diagnostic surgery that can be used to identify the presence

25. Topic Brief: Updating Pharmacotherapy for Adults with Alcohol Use Disorders in Outpatient Settings (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/nt_docs/topic-brief-updating-pharmacotherapy.pdf
    September 30, 2022 - differential effectiveness of AUD medications by demographic and genetic characteristics, as well as the presence … whether the effectiveness of Varenicline27, 28 and Naltrexone29 based treatments were moderated by presence … N-Acetylcysteine,35 Mirtazapine,36 and Lorazepam plus Disulfiram42 for the treatment of AUD varied by presence … The systematic review examined whether the presence of the A118G genotype of the OPRM1 gene (the gene … The second RCT45 assessed whether the presence of a rs29220 mutation in the GABBR1 gene (the gene encoding

26. Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix D1 Tables (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d1.xlsx
    January 01, 2024 - clinically localized prostate adenocarcinoma (cN0M0 on conventional imaging), standard-of-care workup presence … the trial and presumed cured; a simulated volume exceeding 1,000 mL; previous pelvic radiotherapy; presence … Prior malignancies, presence of small-cell, neuroendocrine or transitional-cell carcinoma in the biopsy … : stage T3a-T3b, biopsy Gleason score (GS) of 8–10; pretreatment PSA level (iPSA) >20 ng/mL, or the presence

27. CER 220 Evidence Summary: Comparative Effectiveness of Analgesics To Reduce Acute Pain in the Prehospital Setting (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-220-analgesics-acute-pain-summary.pdf
    September 01, 2019 - versus NSAIDs, combination opioid and ketamine versus opioids) and outcomes (pain severity, pain presence … Patient with moderate to severe, acute pain Health Outcomes Pain score Presence of pain Time … clinically important difference (+) Insufficient No clinically important differencec (++) Pain presence … Opioid Versus Switching to Ketamine Pain severity (continuous) Ketamine may be more effective (+) Pain presence

28. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
    May 24, 2010 - Use of the term CDAD indicates the major focus of this review is on the presence of clinical disease … There are increasing numbers of diagnostic tests designed to detect either the presence of the organism … diagnostic tests rely on two-step procedures, making use of inexpensive, fast screening tests for the presence … The focus of the review is the clinical population, and the presence of toxinogenic organisms is of

29. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/musculoskeletal-complaints-tests-children_research-protocol.pdf
    September 29, 2010 - The rheumatoid factor (RF) test is the most commonly used serological test to determine the presence … isotypes (e.g., IgA, IgG, IgD, IgM, and IgE), but 19S IgM RF is the most frequently used isotype.4 The presence … The CCP test detects the presence of autoantibodies to citrullinated peptides found in the patient’ … Rheumatoid Arthritis in adults.7,19 Although the pathophysiological link is not yet fully understood, the presence … disease characterized by widespread inflammation of blood vessels and connective tissues and by the presence

30. Topic-Brief3-Sud (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief3-SUD.pdf
    April 01, 2021 - medications used to treat pain, concurrent use of other substances (e.g. alcohol, cannabis), and the presence … and substance use disorder may be greater in Medicare populations due to higher medical complexity, presence … be more challenging that other populations with these conditions due to higher medical complexity, presence … of persons entitled to Medicare may be particularly challenging due to greater medical complexity, presence … pain.53 A systematic review identified and described mobile applications for opioid use disorder (presence

31. Topic-Brief3-Sud (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief3-SUD.pdf
    April 01, 2021 - medications used to treat pain, concurrent use of other substances (e.g. alcohol, cannabis), and the presence … and substance use disorder may be greater in Medicare populations due to higher medical complexity, presence … be more challenging that other populations with these conditions due to higher medical complexity, presence … of persons entitled to Medicare may be particularly challenging due to greater medical complexity, presence … pain.53 A systematic review identified and described mobile applications for opioid use disorder (presence

32. Topic-Brief1-Care-Coordination (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief1-care-coordination.pdf
    April 01, 2021 - population is particularly vulnerable during transitions of care due to higher medical complexity, presence … population is particularly vulnerable during transitions of care due to higher medical complexity, presence … entitled to Medicare may be particularly vulnerable due to greater medical complexity, older age, or presence … in or eligible for Medicare, or who would be similar to those enrolled in Medicare based on age, presence

33. Topic-Brief1-Care-Coordination (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief1-care-coordination.pdf
    April 01, 2021 - population is particularly vulnerable during transitions of care due to higher medical complexity, presence … population is particularly vulnerable during transitions of care due to higher medical complexity, presence … entitled to Medicare may be particularly vulnerable due to greater medical complexity, older age, or presence … in or eligible for Medicare, or who would be similar to those enrolled in Medicare based on age, presence

34. Whole-Body Vibration Therapy for Osteoporosis (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
    January 01, 2020 - of Men Presence of Minorities Comorbidities Prior Treatments for Osteoporosis Gusi, 200621 … of Men Presence of Minorities Comorbidities Prior Treatments for Osteoporosis Semler, 200871 … of Men Presence of Minorities Comorbidities Prior Treatments for Osteoporosis Verschueren … of Men Presence of Minorities Comorbidities Prior Treatments for Osteoporosis Russo, 200352 … of Men Presence of Minorities Comorbidities Prior Treatments for Osteoporosis Gilsanz, 200647

35. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0365_10-28-2010.pdf
    January 01, 2010 - studies can be synthesized to enable clinicians to recommend particular PTSD treatments based on the presence

36. Ch 3-User-Guide-To-Ocer 130129 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/ch_3-user-guide-to-ocer_130129.pdf
    September 21, 2012 - embody characteristics that vary between individuals, such as age, sex, disease etiology and severity, presence … Despite the presence of this heterogeneity, many studies estimate an average treatment effect (ATE) … The presence or absence of statistical interaction depends on various mathematical aspects of the regression … pathophysiologic variables (e.g., timing after stroke, stable or unstable angina); (3) comorbidities (e.g., presence

37. Topic 0549 Diagnosis and Management of Gout NSD _SJ Clean (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0648-140819.pdf
    June 24, 2014 - primarily on clinical signs and symptoms, and usually without the use of synovial fluid analysis for the presence

38. Acs-Pci-Adjunctive-Devices Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-pci-adjunctive-devices_research-protocol.pdf
    July 01, 2010 - ejection fraction, primary or rescue PCI, use of glycoprotein IIb/IIIa inhibitors, ischemia time, presence … inspection of funnel plots and Egger’s weighted regression statistics will be used to assess for the presence … smoking history, history of diabetes, type of ACS, ejection fraction, ischemia time, pre-PCI TIMI flow, presence

39. Glasgow Coma Scale for Field Triage of Trauma: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/field-triage-glascow_executive.pdf
    January 01, 2017 - These include variability in patient populations (e.g., type of trauma, demographic characteristics, presence … head Abbreviated Injury Scale (AIS) score greater than 2 (AIS-2005) or greater than 3 (AIS- 1998), presence … associated with slightly higher sensitivity than the SMS (cutoff of ≤1) for severe brain injury based on presence … evidence, its applicability to specific patient populations (e.g., specific type of trauma, age, presence … and severity 10 of intoxication, presence of medical comorbidities, and presence of other injuries

40. Research to Improve the Delivery of Clinical Preventive Services to People with Disabilities (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/stakeholder-report_0824.pdf
    August 01, 2024 - in electronic health records) and in the consumer environment (e.g., purchases that may signal the presence … varied experiences of discrimination people with disabilities may encounter that may be related to the presence … questions and projects; • The growth of community-designed and community-led interventions; and • The presence